The Efficacy of Jinlida Granules on Type 2 Diabetes Mellitus was Discussed Based on the Theory of “Treating from Spleen”
DOI:
https://doi.org/10.18063/jmds.v10i2.861Keywords:
Treating from the spleen, Jinlida granules, Type 2 diabetesAbstract
Objective: To explore the clinical efficacy of the spleen-strengthening and body fluid-moving formula, Jinlida Granules, in combination with Metformin for treating type 2 diabetes based on the theory of ‘treating from the spleen.’ Methods: A case-control study was conducted, involving 62 patients with type 2 diabetes admitted between August 2022 and December 2024. These patients were randomly divided into a control group (31 patients treated with Metformin) and an observation group (31 patients treated with Jinlida Granules), both for a 12-week course of treatment. The study compared changes in blood glucose levels (FPG, 2hPG, HbA1c), lipid levels (TC, TG, LDL, HDL), and pancreatic function indicators (HOMA-B, HOMA-IR) before and after treatment in both groups, and assessed the overall clinical effectiveness. Results: The overall effectiveness rate of the observation group was 90.3%, significantly higher than the 74.2% in the control group (P < 0.05). After treatment, the FPG in the observation group decreased by 2.1 ± 0.8% mmol/L, and HbA1c decreased by 1.5 ± 0.6%. Additionally, the 2hPG in the observation group was significantly better than that in the control group, with a 18.3 ± 5.2% increase in HOMA-B and a 1.5 ± 0.6% decrease in HOMA-IR, all of which were better than those in the control group (P < 0.05). Conclusion: Jinlida Granules combined with Metformin can significantly improve the glucose and lipid metabolism and pancreatic cell function in patients with type 2 diabetes
References
He Y, Wang Q, 2025, Clinical Observation of Treatment of Type 2 Diabetes Mellitus with Jili Da Granules Combined with Metformin. China Modern Distance Education in Traditional Chinese Medicine, 23(4): 134–137.
Li H, Dong Y, Li M, et al., 2025, Efficacy of Jili Da Granules in Treating Type 2 Diabetes Mellitus with Qi and Yin Deficiency and Mild Cognitive Dysfunction. Journal of Traditional Chinese Medicine of Zhejiang, 60(1): 32–33.
Wang Y, Wu J, Chen M, et al., 2025, The Effects and Mechanisms of Jinlida on Myocardial Fibrosis in Diabetic Cardiomyopathy Rats. Ningxia Medical Journal, 47(1): 8–12.
Wei W, Zhang H, Xu J, et al., 2024, The Effects of Jili Da Granules Combined with Semaglutide on Glucose and Lipid Metabolism, Inflammatory Markers, and Atherosclerosis Indicators in Patients with Type 2 Diabetes and Carotid Atherosclerosis. Modern Biomedical Advances, 24(20): 3923–3925.
Chen Z, 2024, Analysis of the Effect of Jingle Da Granules Combined with Conventional Western Medicine on the Treatment of Coronary Heart Disease with Diabetes. Chinese Community Physicians, 40(28): 56–58.
Luo L, Song C, Wang Z, et al., 2024, Clinical Study on the Combined Use of Teldesol Granules and Lusecetide for the Treatment of Type 2 Diabetes Mellitus. Modern Drugs and Clinics, 39(9): 2360–2364.
Geng P, 2024, Observation and Mechanism of Efficacy of Jili Da Combined with Tongxin Luo in Treating Type 2 Diabetes Mellitus with Coronary Atherosclerotic Heart Disease. Shijiazhuang Second Hospital, Hebei Province, August 19.
Liu S, Zhang J, Yang X, et al., 2024, Clinical Efficacy of Tidila Granules Combined with Detemir Insulin and Liraglutide Injection for the Treatment of Poorly Controlled Type 2 Diabetes Mellitus. Chinese Journal of Modern Medicine, 34(15): 65–70.
Zhang T, Cao S, Zhang S, 2024, Clinical Effects of Jingle Da Granules Combined with Aspart Insulin in the Treatment of Gestational Diabetes Mellitus. Journal of Maternal and Child Health, 3(11): 88–91.
Wang Z, 2024, Study on the Role of Aging Pancreatic β Cells in Prediabetes, thesis, Hebei Medical University.
Wang H, Xu M, 2024, The Effect of Tandai Granules Combined with Aspart Insulin on Glucose Metabolism and Adverse Outcomes in Pregnant Women with Gestational Diabetes. New World of Diabetes, 27(10): 68–71.
Ke L, Lin X, Chen J, et al., 2024, Clinical Efficacy of Jili Da Granules in the Auxiliary Treatment of Diabetic Peripheral Neuropathy with Cognitive Dysfunction. Lianjin Military Medical Journal, 38(2): 133–137 + 156.
Liu Q, Zhang X, 2024, Clinical Efficacy and Effects on Immune Function of Jili Da Granules Combined with Tripterygium wilfordii P. D. Tablets in the Treatment of Diabetic Nephropathy. China’s Rational Drug Use Exploration, 21(2): 89–95.
Wang L, 2020, Chinese Medicine Acupoint Patch Therapy Combined with Jinlida Pill. China’s Naturopathy, 28(10): 60–62.
